Your browser doesn't support javascript.
loading
Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance.
Costello, Harry; Roiser, Jonathan P; Howard, Robert.
Afiliación
  • Costello H; Institute of Cognitive Neuroscience, University College London, London, UK.
  • Roiser JP; Institute of Cognitive Neuroscience, University College London, London, UK.
  • Howard R; Division of Psychiatry, University College London, London, UK.
Psychol Med ; 53(3): 654-667, 2023 02.
Article en En | MEDLINE | ID: mdl-36621964
ABSTRACT
Depression in dementia is common, disabling and causes significant distress to patients and carers. Despite widespread use of antidepressants for depression in dementia, there is no evidence of therapeutic efficacy, and their use is potentially harmful in this patient group. Depression in dementia has poor outcomes and effective treatments are urgently needed. Understanding why antidepressants are ineffective in depression in dementia could provide insight into their mechanism of action and aid identification of new therapeutic targets. In this review we discuss why depression in dementia may be a distinct entity, current theories of how antidepressants work and how these mechanisms of action may be affected by disease processes in dementia. We also consider why clinicians continue to prescribe antidepressants in dementia, and novel approaches to understand and identify effective treatments for patients living with depression and dementia.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Demencia / Antidepresivos Límite: Humans Idioma: En Revista: Psychol Med Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Demencia / Antidepresivos Límite: Humans Idioma: En Revista: Psychol Med Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido